Norges Bank
ETON icon

Norges Bank’s Eton Pharmaceutcials ETON Stock Holding History

Norges Bank’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.14M Buy
+169,500
New +$4.97M ﹤0.01% 1360

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank's ETON Position: Q2 2026 in Review

Norges Bank opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 169,500 shares worth $6.14M. The stake represents ﹤0.01% of the portfolio and ranks #1360 among its holdings.

94 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Norges Bank held 169,500 shares of Eton Pharmaceutcials worth $6.14M as of Q2 2026.
  • Eton Pharmaceutcials was a new Norges Bank position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1360 holding.
  • 94 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.